Zydus Cadila expands into French generics market

By Elaine Rigoli

Tampa, Fla., April 5 - Cadila Healthcare Ltd. announced that Zydus France SAS has entered into an agreement with Evolupharn, a large distribution channel with a network of pharmacies, in France.

The agreement creates additional distribution strength for Zydus France by providing access to 2,250 more pharmacists and supplements its existing marketing force, according to a news release.

Zydus France SAS currently markets 76 generic presentations and expects to launch 30 products over the next two years.

The French generics market, valued at €1.5 billion, is growing at the rate of 24% annually, the release said.

The company also said it has accepted an offer of €7 million from Aerocid of France for 29 products, a mix of prescription and over-the-counter, in the branded business of Zydus France SAS.

Zydus Cadila is a pharmaceutical company with headquarters in Ahmedabad, India.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.